SEC Filing Summary: Alphabet Inc. Form 13F
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Alphabet Inc. for the reporting period ending March 31, 2023. The document discloses equity securities held by the company that are subject to Section 13(f) of the Securities Exchange Act of 1934. It details the issuer, class of security, CUSIP, value, and voting authority for each holding.
Key Financial Metrics and Holdings
The filing lists specific equity positions rather than Alphabet's own financial performance (revenue, profit, or cash flow). Key metrics from the table include:
- Portfolio Composition: The disclosed holdings are heavily concentrated in the biotechnology, healthcare, and technology sectors.
- Top Holdings by Value:
- Crowdstrike Hldgs Inc: $159,707,226 (1,163,538 shares)
- UiPath Inc (CL A): $239,914,255 (13,662,543 shares)
- Verve Therapeutics Inc: $149,513,611 (10,368,489 shares)
- Prime Medicine, Inc: $163,401,662 (13,284,688 shares)
- Planet Labs PBC: $125,534,579 (31,942,641 shares)
- Voting Authority: The filing indicates "Sole" voting authority for the majority of listed positions, with some instances of "Shared" or "None" authority.
Material Changes
The filing text provided is a static snapshot of holdings as of March 31, 2023. It does not provide comparative data against the prior quarter (December 31, 2022) or prior year. Therefore, material changes in position size, new acquisitions, or divestitures cannot be determined from this document alone.
Guidance, Outlook, and Risks
This Form 13F is a regulatory disclosure of holdings and does not contain management commentary, financial guidance, outlook, risk factors, or contingencies regarding Alphabet Inc.'s operations or the future performance of the underlying securities.
Investor Verification Checklist
- Verify the total aggregate value of the disclosed portfolio against Alphabet's quarterly 10-Q filings to assess the proportion of assets held in these specific equities.
- Compare this list with the previous quarter's 13F filing to identify new entries (e.g., specific biotech firms) or exits.
- Confirm the "Value" column reflects the market price as of March 31, 2023, noting that these are historical values and not current market prices.
- Review the "Voting Authority" column to understand the extent of Alphabet's control over the listed companies.